P J Feczko|S M Simms|J Iorio|R Halpert - JoVE Visualize

Showing results (131-140 of 251) with videos related to

Pageof 26

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2001

Role of induction of specific hepatic cytochrome P450 isoforms in epoxidation of 4-vinylcyclohexeneS M Fontaine, P B Hoyer, J R Halpert, et al.

Carcinogenesis|November 1, 1990

The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and ratsB J Smith, I G Sipes, J C Stevens, et al.

Archives of Biochemistry and Biophysics|November 1, 1994

Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5G H John, J A Hasler, Y A He, et al.

Genomics Data|July 14, 2016

The draft genome sequence and annotation of the desert woodrat Neotoma lepidaMichael Campbell, Kelly F Oakeson, Mark Yandell, et al.

Archives of Biochemistry and Biophysics|November 15, 1988

The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2D B Duignan, I G Sipes, P J Ciaccio, et al.

Molecular Pharmacology|February 3, 1999

Use of chimeric enzymes and site-directed mutagenesis for identification of three key residues responsible for differences in steroid hydroxylation between canine cytochromes P-450 3A12 and 3A26D J Fraser, Y Q He, G R Harlow, et al.

Biophysical Journal|April 19, 2005

Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probeDmitri R Davydov, Alexandra E Botchkareva, Nadezhda E Davydova, et al.

Molecular Pharmacology|February 21, 2002

Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivationKishore K Khan, You Qun He, Tammy L Domanski, et al.

Toxicology and Applied Pharmacology|April 1, 1994

Selective inhibitors of cytochromes P450J R Halpert, F P Guengerich, J R Bend, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002

Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4Kishore K Khan, You Qun He, Maria Almira Correia, et al.

Pageof 26

Showing results (131-140 of 251) with videos related to

Sort By:

Pageof 26

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2001

Role of induction of specific hepatic cytochrome P450 isoforms in epoxidation of 4-vinylcyclohexeneS M Fontaine, P B Hoyer, J R Halpert, et al.

Carcinogenesis|November 1, 1990

The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and ratsB J Smith, I G Sipes, J C Stevens, et al.

Archives of Biochemistry and Biophysics|November 1, 1994

Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5G H John, J A Hasler, Y A He, et al.

Genomics Data|July 14, 2016

The draft genome sequence and annotation of the desert woodrat Neotoma lepidaMichael Campbell, Kelly F Oakeson, Mark Yandell, et al.

Archives of Biochemistry and Biophysics|November 15, 1988

The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2D B Duignan, I G Sipes, P J Ciaccio, et al.

Molecular Pharmacology|February 3, 1999

Use of chimeric enzymes and site-directed mutagenesis for identification of three key residues responsible for differences in steroid hydroxylation between canine cytochromes P-450 3A12 and 3A26D J Fraser, Y Q He, G R Harlow, et al.

Biophysical Journal|April 19, 2005

Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probeDmitri R Davydov, Alexandra E Botchkareva, Nadezhda E Davydova, et al.

Molecular Pharmacology|February 21, 2002

Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivationKishore K Khan, You Qun He, Tammy L Domanski, et al.

Toxicology and Applied Pharmacology|April 1, 1994

Selective inhibitors of cytochromes P450J R Halpert, F P Guengerich, J R Bend, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002

Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4Kishore K Khan, You Qun He, Maria Almira Correia, et al.

Pageof 26